"Marijuana prohibition applies to everyone, including the sick and dying. Of all the negative consequences of prohibition, none is as tragic as the denial of medicinal cannabis to the tens of thousands of seriously ill patients who could benefit from its therapeutic use. Until Congress is persuaded to amend federal law legalizing prescriptive access to marijuana, states have an obligation to protect patients seeking relief with medical cannabis from arrest and prosecution under state law. Basic compassion and common sense demand that we allow America's seriously ill citizens to use whatever medication is safe and effective to alleviate their pain and suffering." - Keith Stroup, Esq., Founder, NORML
 

Statewide Action Alerts:


 

Update: Companion legislation, S. 5629 has passed the Senate Health Committee and now heads to the full Senate for consideration.

Legislation is moving forward, A. 7006, to allow patients with post-traumatic stress eligible for medical cannabis therapy.

New York is one of the only states with a medical marijuana program that does not allow patients with PTSD access to medical cannabis.

Please use the pre-written letter below to urge your lawmakers to support this effort. 

 
 

Update: On May 11 both bills were referred to the Health Committee

A pair of bills are pending in the Senate to expand patients’ access to medical cannabis.

Senate Bill 6092 expands the pool of patients eligible for medical cannabis access to include those with Alzheimer’s disease, lupus, rheumatoid arthritis and a number of other debilitating diseases. It also removes arbitrary caps imposed on the amount of THC permitted in oral products. 

Senate Bill 6308 allows for additional cannabis providers to operate in the state in order to improve patients’ access.

 
 

Senator Liz Krueger (D) has introduced the Marijuana Regulation and Taxation Act, which is making its way through the New York General Legislature.

The act legalizes possession and cultivation, and would establish a market for legal marijuana for adults 21 and older. 

The ongoing enforcement of cannabis prohibition financially burdens taxpayers, encroaches upon civil liberties, engenders disrespect for the law, impedes legitimate scientific research into the plant's medicinal properties, and disproportionately impacts communities of color.

 

National Action Alerts:


 

Update: On July 31, the Commission released it's initial report without including one mention of medical marijuana. This is after a combined 8,200 messages from NORML and other groups including Marijuana Majority.

The Office of National Drug Control Policy has issued the initial recommendations of President Trump’s Commission on Combating Drug Addiction and the Opioid Crisis without one reference to medical marijuana as a part of a plan to address the ongoing epidemic of opioid misuse and abuse.

Nonetheless, this administration continues to express skepticism with regard to the safety and efficacy of medical marijuana. It’s time they learn the facts!

Send the pre-written letter to the ONDCP Commission to educate them to the positive role that cannabis access plays in curtailing opioid abuse. You can also contact the commission at (202) 395-6709.

 
 

The Ending Federal Marijuana Prohibition Act of 2017, HR 1227, eliminates federal criminal penalties for possessing and growing the plant. This legislation gives states the power and flexibility to establish their own marijuana policies free from federal interference.

With the recent confirmation of militant marijuana prohibitionist Jeff Sessions to the position of US Attorney General, and with comments from the Trump administration warning of a coming federal crackdown in adult use states, passage of The Ending Federal Marijuana Prohibition Act is necessary to ensure that marijuana consumers are protected from undue federal interference.

 
 

 With public support for reforming marijuana laws at an all time high, Reps. Earl Blumenauer (D-OR), Dana Rohrabacher (R-CA), Jared Polis (D-CO), and Don Young (R-AK) have formed the first-ever Congressional Cannabis Caucus to develop and promote sensible cannabis policy reform and work to ease the tension between federal and state cannabis laws. 

Never in modern history has there existed greater public support for ending the nation's nearly century-long experiment with marijuana prohibition. The continued criminalization of adult marijuana use is out-of-step with the views of adults throughout America, 93% of whom support medical marijuana (Quinnipiac, 2017) and 60 percent of whom endorse the outright legalization of recreational cannabis (Gallup, 2016). 

The leadership displayed by Representatives Rohrabacher, Blumenauer, Polis, and Young is a testament to this growing public consensus. The official establishment of this Caucus represents our growing, bipartisan support in Congress.